Was macht Fluicell?
Unternehmensprofil
Fluicell AB engages in the provision of fluid platforms for multi-functional pipettes for cell-based pharmacology research. Its products include Biopen Prime and Flex, Dynaflow Resolve, and Biopixlas. The company was founded by Aldo Jesorka, Alar Ainla, and Gavin David Michael Jeffries on January 2, 2012 and is headquartered in Molndal, Sweden.
Chart der Fluicell Aktie
Charttool öffnen
Wir finden für unsere Leser softwaregestützt die besten Aktien der Welt
und schreiben darüber, wie man diese handeln muss, um Geld zu verdienen.